Injection of Glatiramer Acetate Depot Results in T1 and T2 Lesion Reduction in Relapsing MS.

Published Date: 01 Mar 2023

Secondary results from a phase 3 study show that patients with multiple sclerosis receiving glatiramer acetate depot therapy have significantly fewer new T1 enhancing lesions and new, enlarging hyperintense T2 lesions.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Children with cancer experience much less pain at home when using a pain monitoring app.

2.

No Cellphone, Brain Cancer Link; Testosterone Paradox; Breast Density and Cancer

3.

In a clinical trial, "3D mammography" nearly reduces the incidence of breast cancer between two screening exams.

4.

Check for eating disorders in bipolar disorder patients.

5.

A new theranostic drug targets different cancer types.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot